Saturday, July 25, 2026

pharma · Asthma · Multiple Sclerosis · TEVA

Teva Pharma

Teva Pharma trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV HQ
126 Employees
Public company Type
TEVA · NYSE Ticker
Company details
Intelligence · Clinical Trials

Teva Pharma clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to Teva Pharma programs — each row shows trial ID, program name, phase, status, and indication.

Teva Pharma trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Teva Pharma.

  1. Talampanel — Phase 2

    Clinical update
  2. Fremanezumab — Phase 2

    Clinical update
  3. armodafinil — Phase 2

    Clinical update
  4. Oral CEP-701 — Phase 2

    Clinical update
  5. TV-44749 — Phase 3

    Clinical update
  6. TEV-53408 — Phase 1

    Clinical update
  7. TL011 — Phase 1

    Clinical update
  8. Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis

    Patent grant

Trial registry

10 studies